TCTR20180723002招募中4 期
Safety, humoral and cellular immunity response of double-dose compare to standard-dose hepatitis B revaccinaiton in children after liver transplantaiton
Chulalonkorn University0 个研究点目标入组 72 人开始时间: 2018年7月23日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- N/A (No limit) 至 18 Years（—）
- 性别
- All
入选标准
- •Participants age less than 18 years old, post liver transplantation, do not on steroid as immunosuppressants, antiHBs antibody less than 100 mIU/m
排除标准
- •Participant who has serious illness such as fever, loss follow up, on steroid as immunosuppressant therapy.
研究者
相似试验
Unknown
3 期
BNT162b2 in Thai childreImmunization to prevent COVID-19 infection.COVID-19, vaccination, BNT162b2, children, liver transplant, immunogenicity, safetyTCTR20220708003Chulalongkorn University33
招募中
3 期
Safety, humoral and cellular immunogenicity after coronavirus disease-19 (COVID-19) vaccination (BNT162b2) in 12 to 18 year-old children after liver transplantatioImmunization to prevent COVID-19 infectionCOVID-19, vaccination, BNT162b2, adolescent, liver transplant, immunogenicity, safetyTCTR20210830002Chulalongkorn university44
已完成
1 期
Investigating of the Immunogenicity and Safety of Lactococcus Lactis Vaccine Related to Human Papillomavirus Type 16IRCT20190504043464N1Iran University of Medical Sciences200
尚未招募
3 期
Study of immunity to flu vaccine.CTRI/2021/11/037859Christian Medical College Vellore
已完成
1 期
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months.Prophylaxis against infections diseases: Diphtheria, Tetanus, B. pertussis, H. influenzae type b and hepatitis B.RPCEC00000103Center for Genetic Engineering and Biotechnology (CIGB).624